散瞳提升致密性白内障人工晶状体计算精准度
赵振波 , 杨吉琨 , 韩冬 , 石采灵 , 王换平 , 程悦 , 刘丹霞 , 马立威
中国医科大学学报 ›› 2026, Vol. 55 ›› Issue (8) : 749 -753.
散瞳提升致密性白内障人工晶状体计算精准度
Pupil dilation for improved intraocular lens calculation accuracy in dense cataract
目的 评估散瞳方案对扫频源光学相干断层成像 (SS-OCT) 技术初测眼轴信号质量不佳的致密性白内障测量参数及人工晶状体 (IOL) 度数预测的影响。方法 选择2024年3月7日至2025年3月7日间于沈阳爱尔卓越眼科医院使用SS-OCT生物测量仪初测信号质量不佳的致密性白内障患者50例 (50眼)。给予患眼散瞳后复测,记录散瞳前后及对侧眼测量参数[感叹号标识、眼轴长度 (AL)、中央角膜厚度 (CCT)、前房深度 (ACD)、晶状体厚度 (LT)、中央角膜曲率KSE、白到白距离 (WTW)、瞳孔直径 (PD) ]及重复性标准差 (SDAL和SDLT) 等。根据SS-OCT二维扫描图像记录晶状体混浊类型。进行A超检查并记录AL值。采用Barrett Universal Ⅱ公式计算IOL度数。采用Pearson相关分析、配对t检验、Wilcoxon符号秩检验、方差分析进行差异比较。结果 散瞳后,66%的患眼不再提示信号质量不佳,其效果排序为:后囊下性>核性>皮质性=混合性。散瞳后AL缩短0.02 (0.01~0.03) mm,SDAL下降8 (5.5~10.5) μm,CCT增厚 (7.59±9.50) μm,ACD加深 (0.09±0.06) mm,WTW增大 (0.16±0.32) mm,PD增大 (3.89±0.79) mm。AL、SDAL、CCT、ACD、WTW、PD散瞳前后变化显著,差异有统计学意义 (P < 0.05)。散瞳后,LT增厚 (0.04±0.19) mm,SDLT降低1.50 (1.00~7.00) μm,KSE增加 (0.01±0.26) D,较散瞳前无显著变化 (P > 0.05)。未散瞳状态下,患眼A超AL测量结果为23.51 (22.84~24.43) mm。将A超、患眼散瞳前后及对侧眼参数输入Barrett UniversalⅡ公式计算IOL度数,四者差异无统计学意义 (P > 0.05)。结论 致密性白内障患者采用SS-OCT生物测量仪进行眼轴测量时,若遇眼轴测量信号衰减、信号质量欠佳的情况,散瞳可改善眼轴测量信号质量,且散瞳后数据亦可用于IOL度数计算。因此,散瞳策略可提高屈光性白内障手术前评估准确性。
Objective To evaluate the effect of pupil dilation on biometric parameters and intraocular lens (IOL) power in dense cataracts with low-quality axial length (AL) measurements on swept-source optical coherence tomography (SS-OCT). Methods This prospective observational study enrolled 50 patients (50 eyes) with dense cataract. Patients with the yellow “!” mark on SS-OCT that indicates signal attenuation and low-quality AL measurements underwent pupil dilation before an additional SS-OCT. We recorded the following SS-OCT parameters (in both eyes,before and after dilation):signal attenuation indicator (yellow “!” mark),AL,repeatability standard deviation of AL (SDAL),central corneal thickness (CCT),anterior chamber depth (ACD),lens thickness (LT),repeatability standard deviation of LT (SDLT),corneal curvature (KSE),corneal diameter (WTW),and pupil diameter (PD). SS-OCT B-scan images were used to classify cataract types. The AL of the affected eye was measured using A-scan ultrasound. The Barrett UniversalⅡFormula was used for IOL power calculations. Analyses of variance,Wilcoxon signed-rank tests,paired t-tests,and Pearson’s correlation analyses were performed. Results In 66% of cases,the yellow “!” mark disappeared after pupil dilation,with the following efficacy ranking:posterior subcapsular>nuclear > cortical = mixed. After pupil dilation,significant changes were observed (all P < 0.05):the AL decreased by 0.02 (0.01-0.03) mm,SDAL by 8.00 (5.5-10.5) μm,and ACD by 0.09±0.06 mm,whereas the CCT increased by 7.59±9.50 μm,WTW by 0.16±0.32 mm,and PD by 3.89±0.79 mm. No significant changes were observed in the LT,SDLT and KSE groups (P > 0.05). On A-scan ultrasound,the AL of the affected eye was 23.51 (22.84-24.43) mm whereas,on SS-OCT,the AL of the fellow eye was 23.63 (22.97-24.90) mm. Parameters from the A-scan ultrasound before and after pupil dilation,and the fellow eye were input into the Barrett UniversalⅡformula for IOL power calculation,and showed no significant differences (P > 0.05). Binocular comparative analysis (of no pupil dilation and groups stratified by AL) showed no significant changes in IOL power prediction (P > 0.05). Conclusion In dense cataracts,pupil dilation improved signal quality in cases with low-quality AL measurements on SS-OCT. Pupil dilation data are reliable for IOL power prediction,and this highlights their clinical value in enhancing the accuracy of preoperative assessments.
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
TAÑÁ-RIVERO P,TAÑÁ-SANZ S,PASTOR-PASCUAL F, |
| [7] |
TESHIGAWARA T,MEGURO A,MIZUKI N. Influence of pupil dilation on the Barrett universalⅡ(new generation),Haigis (4th generation),and SRK/T (3rd generation) intraocular lens calculation formulas:a retrospective study [J]. BMC Ophthalmol,2020,20 (1):299. DOI:10.1186/s12886-020-01571-1. |
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
张帆,陈彦辰,巫雷, |
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
陈悦,韩雪,胡亚茹, |
| [23] |
|
| [24] |
|
| [25] |
杨娟,杜磊,曾思雨, |
湖南省企业联合基金(2023JJ70040)
爱尔眼科医院集团辽宁省区研究所科研基金(LNI2025X10)
爱尔眼科医院集团科研基金项目创新型医院建设专项(AIF2302D01)
湘江公益基金会技术创新与应用发展专项项目(KY24003)
/
| 〈 |
|
〉 |